Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Support for proxy QOL ratings for prostate cancer patients

    • 8 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Support for proxy QOL ratings for prostate cancer patients. Pharmacoecon. Outcomes News 304, 10 (2001). https://doi.org/10.1007/BF03280232

    Download citation

    Keywords

    • Public Health
    • Clinical Trial
    • Cancer Patient
    • Prostate Cancer
    • Clinical Study